TABLE 1.
Baseline characteristics among patient having a telephone visit during the first wave of the COVID-19 pandemic, n = 139
| Total sample | |
| Age, Mean ± SDa (y) | 53.3 ± 7.37 |
| Type of visitb | |
| New | 21 (15%) |
| Follow-up | 113 (81%) |
| Level of education | |
| Postgraduate | 41 (30%) |
| University | 49 (35%) |
| College | 40 (29%) |
| High school | 9 (6%) |
| Elementary school | 0 (0%) |
| Home community | |
| Living in the Greater Toronto Area | 117 (84%) |
| Living outside the Greater Toronto Area | 22 (16%) |
| Current menopause managementc | |
| Hormone therapy | 94 (68%) |
| Nonhormonal prescription medication | 15 (11%) |
| Over the counter nonprescription medication | 13 (9%) |
| Lifestyle modification | 13 (9%) |
| No treatment | 24 (17%) |
| New menopause therapy started during the COVID-19 pandemic | |
| Yes | 31 (22%) |
| No | 108 (78%) |
| Menopause therapy adjusted during COVID-19 pandemic | |
| Yes | 54 (39%) |
| No | 85 (61%) |
a
Standard deviation.
b
Follow-up patients may have also had a new visit during the study period.
c
Participants may have selected more than one option.